Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Much evidence reveals an important link between gut microbiota and the heart. In particular, the gut microbiota plays a key role in the onset of cardiovascular (CV) disease, including heart failure (HF). In HF, splanchnic hypoperfusion causes intestinal ischemia resulting in the translocation of bacteria and their metabolites into the blood circulation. Among these, the most important is the Trimethylamine N-Oxide (TMAO), which is responsible through various mechanisms for pathological processes in different organs and tissues. In this review, we summarise the complex interaction between gut microbiota and CV disease, particularly with HF, and the possible strategies to influence its composition and function. Finally, we highlight the potential role of TMAO as a novel prognostic marker and new therapeutic target of HF..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Preprints.org - (2023) vom: 01. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Belli, Martina [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.20944/preprints202306.2222.v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
preprintsorg040063526 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | preprintsorg040063526 | ||
| 003 | DE-627 | ||
| 005 | 20231205144740.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230703s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.20944/preprints202306.2222.v1 |2 doi | |
| 024 | 7 | |a 10.20944/preprints202306.2222.v1 |2 doi | |
| 035 | |a (DE-627)preprintsorg040063526 | ||
| 035 | |a (preprintsorg)10.20944/preprints202306.2222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Belli, Martina |e verfasserin |0 (orcid)0000-0003-3648-9277 |4 aut | |
| 245 | 1 | 0 | |a Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Much evidence reveals an important link between gut microbiota and the heart. In particular, the gut microbiota plays a key role in the onset of cardiovascular (CV) disease, including heart failure (HF). In HF, splanchnic hypoperfusion causes intestinal ischemia resulting in the translocation of bacteria and their metabolites into the blood circulation. Among these, the most important is the Trimethylamine N-Oxide (TMAO), which is responsible through various mechanisms for pathological processes in different organs and tissues. In this review, we summarise the complex interaction between gut microbiota and CV disease, particularly with HF, and the possible strategies to influence its composition and function. Finally, we highlight the potential role of TMAO as a novel prognostic marker and new therapeutic target of HF. | ||
| 700 | 1 | |a Barone, Lucy |0 (orcid)0000-0001-9476-9168 |4 aut | |
| 700 | 1 | |a Longo, Susanna |4 aut | |
| 700 | 1 | |a Prandi, Francesca Romana |0 (orcid)0000-0003-1878-8871 |4 aut | |
| 700 | 1 | |a Lecis, Dalgisio |4 aut | |
| 700 | 1 | |a Mollace, Rocco |0 (orcid)0000-0002-7106-5595 |4 aut | |
| 700 | 1 | |a Margonato, Davide |0 (orcid)0000-0002-5817-6901 |4 aut | |
| 700 | 1 | |a Muscoli, Saverio |4 aut | |
| 700 | 1 | |a Sergi, Domenico |4 aut | |
| 700 | 1 | |a Federici, Massimo |4 aut | |
| 700 | 1 | |a Barillà, Francesco |0 (orcid)0000-0003-0594-7212 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Preprints.org |g (2023) vom: 01. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:01 |g month:08 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms241511971 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20944/preprints202306.2222.v1 |z kostenfrei |3 Volltext |
| 912 | |a preprintsorg | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 01 |c 08 | ||